NASDAQ: IGMSIgm Biosciences Inc Stock Ownership - Who owns Igm Biosciences?
Insider buying vs selling
Have Igm Biosciences Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Baker Bros Advisors LP | Director | 2024-03-28 | 89,407 | $9.62 | $860.01kBuy |
| Baker Bros Advisors LP | Director | 2024-03-28 | 8,066 | $9.62 | $77.59kBuy |
| Baker Bros Advisors LP | Director | 2024-03-27 | 8,439 | $9.27 | $78.20kBuy |
| Baker Bros Advisors LP | Director | 2024-03-27 | 761 | $9.27 | $7.05kBuy |
| Baker Bros Advisors LP | Director | 2024-03-27 | 17,101 | $9.22 | $157.69kBuy |
| Baker Bros Advisors LP | Director | 2024-03-27 | 1,543 | $9.22 | $14.23kBuy |
| Baker Bros Advisors LP | Director | 2024-03-26 | 22,344 | $8.26 | $184.61kBuy |
| Baker Bros Advisors LP | Director | 2024-03-26 | 247,656 | $8.26 | $2.05MBuy |
| Bruce Keyt | CHIEF SCIENTIFIC OFFICER | 2024-03-14 | 1,844 | $10.17 | $18.76kSell |
| Chris H. Takimoto | CHIEF MEDICAL OFFICER | 2024-03-14 | 2,535 | $10.17 | $25.78kSell |
IGMS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when IGMS insiders and whales buy or sell their stock.
IGMS Shareholders
What type of owners hold Igm Biosciences Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Jakob Haldor Topsoe | 17.76% | 10,485,418 | $88.18M | Insider |
| Topsoe Holding A. Haldor | 17.62% | 10,400,564 | $87.47M | Insider |
| Redmile Group LLC | 10.45% | 6,167,394 | $51.87M | Insider |
| Baker Bros Advisors LP | 6.93% | 4,088,322 | $34.38M | Institution |
| Price T Rowe Associates Inc | 6.59% | 3,888,023 | $32.70M | Institution |
| Baker Bros Advisors LP | 6.36% | 3,755,474 | $31.58M | Insider |
| Artal Group Sa | 5.22% | 3,080,422 | $25.91M | Institution |
| Redmile Group LLC | 5.21% | 3,072,478 | $25.84M | Institution |
| Fmr LLC | 2.23% | 1,317,341 | $11.08M | Institution |
| Goldman Sachs Group Inc | 2.17% | 1,278,619 | $10.75M | Institution |
IGMS vs Biotech Stocks
Igm Biosciences Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.